Article
Polymorphisms in the lipopolysaccharide-binding protein and bactericidal/permeability-increasing protein in patients with myocardial infarction.
Clinical chemistry and laboratory medicine - 1 Nov 2002
Hubacek Jaroslav A, Pitha Jan, Skodová Zdena, Adámková Vera, Podrapska Ivana, Schmitz Gerd, Poledne Rudolf
Abstract excerpt
Gram-negative bacterial infection, namely Chlamydia pneumoniae has been recently discussed as a risk factor for myocardial infarction. The lipopolysaccharide-binding protein (LBP) and the bactericidal/permeability-increasing protein (BPI) play a role in the processes leading to recognition and neutralisation of the Chlamydia pneumoniae and their endotoxins lipopolysaccharides (LPS). LPS interact with plasma LBP,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
